1-9 of 9
John P. Leonard, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Idelalisib, a Selective Inhibitor Of PI3Kδ, In Combination With Bendamustine, Fludarabine Or Chlorambucil In Patients With Relapsed Or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)

Sven De Vos, MD, PhD, Richard R. Furman, MD, Jacqueline C. Barrientos, MD, Nina D. Wagner-Johnston, MD, Ian Flinn, MD, PhD, Jeff P. Sharman, MD, Thomas Boyd, MD, John P. Leonard, M.D., Roger Dansey, MD, Yeonhee Kim, PhD, Leanne M. Holes, Ronald L. Dubowy, MD, Steven E. Coutre, MD
Journal: Blood
Blood (2013) 122 (21): 2878.
https://doi.org/10.1182/blood.V122.21.2878.2878
Published: 2013
Journal Articles

Minimal Residual Disease (MRD) Status Following Induction Chemo-Immunotherapy Predicts Progression-Free Survival In Mantle Cell Lymphoma (MCL): CALGB 50403 (Alliance)

Noreen Fulton, B.S., Jeffrey Johnson, M.S., Lawrence D. Kaplan, M.D., Greg Koval, B.S., Greg Malnassy, B.S., Sin-Ho Jung, Ph.D., Steve Devine, M.D., Thomas C. Shea, M.D., John P. Leonard, M.D., Bruce D. Cheson, M.D., Wendy Stock, M.D.
Journal: Blood
Blood (2013) 122 (21): 3002.
https://doi.org/10.1182/blood.V122.21.3002.3002
Published: 2013
Journal Articles

The Combination Of Palbociclib Plus Bortezomib Is Safe and Active In Patients With Previously Treated Mantle Cell Lymphoma: Final Results Of a Phase I Trial

Peter Martin, MD, Maurizio DiLiberto, PhD, Christopher E Mason, PhD, Scott A Ely, M.D., Jia Ruan, MD, PhD, Richard R. Furman, MD, David Chiron, PhD, Xiangao Huang, PhD, David C Madoff, M.D., Jonathan Navi, Jessica Lewis, PA-C, Alison Bender, PA-C, Amelyn Rodriguez, RN, June Greenberg, RN, Morton Coleman, MD, Selina Chen-Kiang, PhD, John P. Leonard, M.D.
Journal: Blood
Blood (2013) 122 (21): 4393.
https://doi.org/10.1182/blood.V122.21.4393.4393
Published: 2013
Journal Articles

Phase Ib Study Of Combination Epigenetic Therapy With 5-Azacitidine and Vorinostat In Patients With Relapsed Or Refractory DLBCL

Tiffany Tang, MD, Peter Martin, MD, Rebecca L. Elstrom, MD, Jia Ruan, MD, PhD, Richard R. Furman, MD, Arcania Garcia, June Greenberg, RN, Amelyn Rodriguez, RN, Alison Bender, PA-C, Jessica Lewis, PA-C, Ari Melnick, MD, Leandro Cerchietti, MD, John P. Leonard, M.D.
Journal: Blood
Blood (2013) 122 (21): 4339.
https://doi.org/10.1182/blood.V122.21.4339.4339
Published: 2013
Journal Articles

Chemo-Immunotherapy Combination Of Idelalisib With Bendamustine/Rituximab Or Chlorambucil/Rituximab In Patients With Relapsed/Refractory CLL Demonstrates Efficacy and Tolerability

Jacqueline C. Barrientos, MD, Nina D. Wagner-Johnston, MD, Sven De Vos, MD, PhD, Steven E. Coutre, MD, Marshall T. Schreeder, MD, MPH, Ian Flinn, MD, PhD, Jeff P. Sharman, MD, Kanti R. Rai, MD, John P. Leonard, M.D., Roger Dansey, MD, Yeonhee Kim, PhD, Leanne M. Holes, Henry Adewoye, MD, Richard R. Furman, MD
Journal: Blood
Blood (2013) 122 (21): 4176.
https://doi.org/10.1182/blood.V122.21.4176.4176
Published: 2013
Journal Articles

Selective Inhibition of CDK4 and CDK6 Primes Chemoresistant MCL Cells for Killing by Proteasome Inhibitor Bortezomib by Activating Cell Cycle-Coupled Apoptosis

Maurizio Di Li berto, Ph.D., Xiangao Huang, Ph.D., Amy Chadburn, M.D., Peter Martin, M.D., Ruben Niesvizky, M.D., Scott Ely, M.D., M.P.H., John P. Leonard, M.D., Selina Chen- Kiang, Ph.D.
Journal: Blood
Blood (2008) 112 (11): 3624.
https://doi.org/10.1182/blood.V112.11.3624.3624
Published: 2008
Journal Articles

Banoxantrone (AQ4N), a Tissue Targeted Prodrug: Results of a Phase 1 Study in Lymphomas.

Richard R. Furman, MD, Nancy L. Bartlett, M.D., Alvin F. Wong, Pharm.D., Leanne M. McCulloch, Pharm.D., Gilbert N. Lam, Ph.D., Todd Rosenthal, Ian Flinn, M.D., John P. Leonard, M.D.
Journal: Blood
Blood (2006) 108 (11): 2429.
https://doi.org/10.1182/blood.V108.11.2429.2429
Published: 2006
Journal Articles

Periocular MALT Lymphomas (Conjunctival/Orbital): Complete Responses with Antibiotic Therapy.

Morton Coleman, M.D., John P. Leonard, M.D., Jules Decter, M.D., Richard R. Furman, M.D., Ruben Niesvizky, M.D., Indira Rollins, David H. Abramson, M.D.
Journal: Blood
Blood (2004) 104 (11): 2493.
https://doi.org/10.1182/blood.V104.11.2493.2493
Published: 2004
Journal Articles

Phase II Study of SGN-30 (Anti-CD30 Monoclonal Antibody) in Patients with Refractory or Recurrent Hodgkin’s Disease.

John P. Leonard, M.D., Joseph D. Rosenblatt, M.D., Nancy L. Bartlett, M.D., Ajay Gopal, M.D., Anas Younes, M.D., David Fisher, M.D., Francine Foss, M.D., Andres Forero, M.D., Steven Bernstein, M.D., Bruce Cheson, M.D., Matthew H. Carabasi, M.D., R. Gregory Bociek, M.D., Bruce Hart, Ph.D., Michael McDonald, M.D.
Journal: Blood
Blood (2004) 104 (11): 2635.
https://doi.org/10.1182/blood.V104.11.2635.2635
Published: 2004